CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- 4 Open-market sale Chief Executive Officer sold 50,000 shares at $41.35 ($2,067,500)
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Executive Officer sold 100,000 shares at an average $38.81 ($3,881,017)
- 4 Open-market buy Director bought 4,000 shares at an average $33.56 ($134,240)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Option exercise Director acquired 77,000 shares (option exercise)
- 4 Open-market sale Director sold 36,000 shares at an average $35.83 ($1,289,891)
- 4 Open-market sale Director sold 26,000 shares at $36.54 ($950,040)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 4 Open-market sale Chief Operating Officer sold 5,401 shares at $40.00 ($216,040)
- 4 Open-market sale Chief Operating Officer sold 23,515 shares at $40.00 ($940,600)
- 4 Open-market sale Director sold 25,000 shares at $36.89 ($922,250)
- 8-K Event Material agreement · New debt or obligation · Shareholder vote results
- 4 Option exercise Chief Financial Officer acquired 43,445 shares (option exercise)
- 4 Grant or award Director acquired 26,571 shares (grant or award)
- SC 13G/A Stake Amended Statement of Ownership
Page 23 of 69 · 1,363 filings